Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins

Blood

Volumn 88, Issue 2, 1996, Pages 542-551

  Higazi, Abd Al Roof ^a   Upson, Rosalyn H ^b   Cohen, Robert L ^b   Manuppello, Joseph ^b   Bognacki, John ^b   Henkin, Jack ^b   McCrae, Keith R ^b   Kounnas, Maria Z ^b   Strickland, Dudley K ^b   Preissner, Klaus T ^b   Lawler, Jack ^b   Cines, Douglas B ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; PLASMINOGEN ACTIVATOR; THROMBOSPONDIN; UROKINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ADHESION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME BINDING; FIBROBLAST; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 8944221645     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.542.bloodjournal882542     Document Type: Article

References (58)

1. Higazi AA-R, Cohen RL, Henkin J, Kniss D, Schwanz BS, Cines DB: Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem 270:17375, 1995
2. Ploug M, Ronne E, Behrendt N, Jensen AL, Blasi F, Dano K: Cellular receptor for urokinase plasminogen activator; carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 266:1926, 1991
3. Kasai S, Arimura H, Nishida M, Suyama T: Proteolytic cleavage of single chain prourokinase induces conformational change which follows activation of the zymogen and production of its high affinity to fibrin. J Biol Chem 260:12382, 1985
4. Ichinose A, Fujikawa K, Suyama T: The activation of prourokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 261:2486, 1986
5. Appella E, Robinson EA, Ulrich SJ, Stoppelli MP, Corti A, Cassani G, Blasi F: The receptor binding sequence of urokinase. J Biol Chem 262:4437, 1987
6. Ellis V, Scully MF, Kakkar VV: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264:2185, 1989
7. Manchanda N, Schwartz BS: Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. J Biol Chem 266:14580, 1991
8. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Neilsen LS, Skrivers L: Plasminogen activator, tissue degradation and cancer. Adv Cancer Res 44:139, 1985
9. Waltz DA, Sailor LZ, Chapman HA: Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest 91:1541, 1992
10. Glass II WF, Radnik RA, Garoni JA, Kreisberg JI: Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells. J Clin Invest 82:1992, 1988
11. Wei W, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994
12. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso G: Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 177:385, 1988
13. Boyle MDP, Chiodo VA, Lawman MJP, Gee AP, Young M: Urokinase: A chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 139:169, 1987
14. Odekon LE, Sato Y, Rifkin DB: Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258, 1992
15. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93:1380, 1994
16. Estreicher A, Mullhauser J, Carpemier J-L, Orci L, Vassalli J-D: The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783, 1990
17. Bastholm L, Nielsen MH, De Mey J, Dano K, Brunner N, Hoyer-Hansen G, Ronne E, Elling F: Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane. Biotech Histochem 69:61, 1994
18. Mulhaupt H, Mazar A, Cines DB, Warhohl M, McKrae KR: Expression of urokinase receptors by human trophoblasts: A histochemical and ultrastructural analysis. Lab Invest 71:392, 1994
19. Dumler I, Petri T, Schleuning W-D: Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 322:37, 1993
20. Dumler I, Petri T, Schleuning W-D: Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett 343:103, 1994
21. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M: Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 190:347, 1993
22. Fibbi G, Magnelli L, Pucci M, Del Rosso M: Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. Exp Cell Res 187:33, 1990
23. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126:259, 1994
24. Nusrat AR, Chapman Jr. HA: An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest 87:1091, 1991
25. Del Rosso M, Pucci M, Fibbi G, Dini G: Interaction of urokinase with specific receptors abolishes the time of committment to terminal differentiation of murine erythroleukemia (Friend) cells. Br J Haematol 66:289, 1987
26. Howell AL, Hunt JA, James TW, Mazar A, Henkin J, Zacharski LR: Urokinase inhibits HL-60 cell proliferation in vitro. Blood Coagul Fibrinolysis 5:445, 1994
27. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D: Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 267:14151, 1992
28. De Petro G, Copeta A, Barlati S: Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res 213:286, 1994
29. Waltz DA, Chapman HA: Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269:14746, 1994
30. Xue W, Kindzelskii AL, Todd III RF, Petty HR: Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol 152:4630, 1994
31. Behrendt N, Ronne E, Dano K: A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminasecatalyzed cross-linking. FEES Lett 336:394, 1993
32. Herz J, Clouthier DE, Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71:411, 1992
33. 2 macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Chem 268:21862, 1993
34. 2 -macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor type-1 complex. J Biol Chem 267:14543, 1992
35. Crowley CW, Cohen RL, Lucas BK, Lius G, Shuman MA, Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90:5021, 1993
36. Bamathan ES, Kuo A, Kariko K, Rosenfeld L, Murray SC, Behrendt N, Ronne E, Weiner D, Henkin J, Cines DB: Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and mRNA. Blood 76:1795, 1990
37. Mazar AP, Buko A, Petros AM, Barnathan ES, Henkin J: Domain analysis of urokinase plasminogen activator (u-PA): Preparation and characterization of intact A-chain molecules. Fibrinolysis 6:49, 1995 (suppl 1)
38. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE: The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J Biol Chem 269:26783, 1994
39. 2-macroglobulin receptor/low density lipoprotein related protein: Multiple regulatory sites for the 39 kDa receptor associated protein. J Biol Chem 267:9035, 1992
40. Preissner KT, Wassmuth R, Müller-Berghaus G: Physiochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 231:349, 1985
41. Barnathan ES, Kuo A, Rosenfeld L, Kariko K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB: Interaction of single chain urokinase type plasminogen activator with human endothelial cells. J Biol Chem 265:2865, 1990
42. Fitzgerald DJ, Fryling CM, Zdanovsky A, Saelinger CB, Kounnas MB, Strickland D, Leppla S: Selection of pseudomonas exotoxin-resistant cells yields mutant cells with altered expression of LRP. J Cell Biol 129:1533, 1995
43. Lawler J, Weinstein R, Hynes RO: Cell attachment to thrombospondin: The role of Arg-Gly-Asp, calcium, and integrin receptors. J Cell Biol 107:2351, 1988
44. Li H, Kuo A, Kochan J, Strickland D, Kariko K, Barnathan E, Cines DB: Endocytosis of urokinase-plasminogen activator inhibitor type I complexes bound to a chimeric transmembrane urokinase inhibitor. J Biol Chem 269:8153, 1994
45. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J Biol Chem 269:25668, 1994
46. Moser TL, Enghild JJ, Pizzo SV, Stack MS: Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem J 307:867, 1995
47. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT: The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 224:344, 1996
48. Harpel PC, Silverstein RL, Pannel R, Gurewich V, Nachman RL: Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. J Biol Chem 265:11289, 1990
49. Lawler J, Simons ER: Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem 258:12098, 1988
50. Lawler J, Derick LH, Connolly JE, Chen J-H, Chao FC: The structure of human platelet thrombospondin. J Biol Chem 260:3762, 1986
51. Dixit VM, Galvin NJ, O'Rourke KM, Frazier WA: Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. J Biol Chem 261:1962, 1986
52. 2+. A spin label approach. FEBS Lett 229:363, 1988
53. Sun X, Skorstengaard K, Mosher DF: Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin. J Cell Biol 118:693, 1992
54. Resnati M, Blasi F. Fazioli F: uPAR transdusces migratory signals through association with a surface trans-membrane adaptor. Fifth International Workshop on Molecular and Cellular Biology of Plasminogen Activation, August 1-5. 1995, Hameelinna, Finland (p 36)
55. Nykjaer A, Petersen CM, Jensen PH, Rasmussen H, Shuman MA, Cohen RL, Gliemann J: The urokinase receptor is a ligand for the cation independent mannose-6-phosphate receptor/insulin-like growth factor II receptor. Fifth International Workshop on Molecular and Cellular Biology of Plasminogen Activation, August 1-5, 1995, Hameelinna, Finland (p 40)
56. 2, CD11b/CD18) during neutrophil polarization. J Immunol 156:297, 1996
57. 2-Macroglobulin receptor/Ldl receptor-related protein (Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 131:1609, 1995
58. Pollanen J, Hedman K, Nielsen LS, Dano K, Vaheri A: Ultrastructural localization of plasma membrane-associated urokinase type plasminogen activator at focal contacts. J Cell Biol 106:87, 1988